Beta-lactamase inhibitory protein Antibody (PACO52166)
The Beta-Lactamase Inhibitory Protein Antibody (PAC052166) is a valuable tool for researchers studying antibiotic resistance mechanisms and bacterial cell wall synthesis. This antibody, produced in rabbits, specifically targets the beta-lactamase inhibitory protein, which plays a key role in bacterial resistance to beta-lactam antibiotics.Beta-lactamase inhibitory protein is a crucial component in the defense mechanisms of bacteria against beta-lactam antibiotics, which are commonly used in clinical settings. By targeting this protein, researchers can better understand how bacteria develop resistance to antibiotics and potentially identify new targets for drug development.
Validated for use in Western blot applications, this antibody allows for the detection and analysis of beta-lactamase inhibitory protein in various bacterial samples. Its high reactivity with human samples makes it an ideal tool for studies in antibiotic resistance, antimicrobial therapy, and microbiology research.By studying the beta-lactamase inhibitory protein, researchers can gain insight into the mechanisms behind antibiotic resistance and work towards developing new strategies to combat this pressing global health issue. This antibody is a valuable resource for advancing research in antimicrobial resistance and improving the effectiveness of antibiotic treatments.
Antibody Name:
Beta-lactamase inhibitory protein Antibody (PACO52166)
Antibody SKU:
PACO52166
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:2000-1:10000, WB:1:500-1:5000
Species Reactivity:
Streptomyces clavuligerus
Immunogen:
Recombinant Streptomyces clavuligerus Beta-lactamase inhibitory protein (37-201AA)
Western Blot. Positive WB detected in Recombinant protein. All lanes: Beta-lactamase inhibitory protein antibody at 4µg/ml. Secondary. Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 33 kDa. Observed band size: 33 kDa.
